Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras homolog family member A (RHOA) mRNA encodes a small GTPase that functions as a molecular switch, cycling between an active GTP-bound and an inactive GDP-bound state (UniProt P61586). The encoded protein is a central regulator of the actin cytoskeleton, influencing cell shape, adhesion, and motility through the activation of downstream effectors like ROCK (Rho-associated protein kinase) (NCBI Gene ID: 387). In many pathological contexts, particularly oncology, RHOA is frequently overexpressed or mutated, driving invasive and metastatic phenotypes in cancers such as diffuse-type gastric cancer and certain T-cell lymphomas (PubMed: 25132177, 24509477). Targeting the RHOA mRNA using RNA interference (RNAi) or antisense oligonucleotides (ASOs) aims to reduce the total pool of RhoA protein, thereby suppressing oncogenic signaling and restoring normal cellular architecture (PubMed: 15622165). While promising, therapeutic development faces challenges regarding the delivery of RNA-based drugs and the potential for toxicity given RhoA's fundamental role in maintaining the structural integrity of healthy cells (PubMed: 28655765).
RNA interference (RNAi) or antisense-mediated degradation of mRNA to prevent the translation of the RhoA protein, thereby inhibiting downstream signaling pathways involved in cell proliferation and migration (PubMed: 15622165).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras homolog family member A (mRNA) (RHOA mRNA).